Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stewart

Showing results (941-950 of 1,171) with videos related to

Pageof 118
Sort By:
Allergy|January 14, 2018
Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis statusJ R Kuiper, A G Hirsch, K Bandeen-Roche, et al.
Cancer|January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyLisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1988
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancyM Mangin, A C Webb, B E Dreyer, et al.
The Journal of Clinical Investigation|October 1, 1983
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cellsS B Rodan, K L Insogna, A M Vignery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemiaS R Nussbaum, R P Warrell, R Rude, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumorsNajat C Daw, Victor M Santana, Lisa C Iacono, et al.
Cancer|January 2, 2009
Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumorsLisa M McGregor, Sheri L Spunt, Victor M Santana, et al.
Journal of Medical Microbiology|September 26, 2009
A quadruplex real-time PCR assay for rapid detection and differentiation of the Clostridium botulinum toxin genes A, B, E and FBenjamin A Satterfield, Alvin F Stewart, Cynthia S Lew, et al.
Headache|December 28, 2020
The migraine signature study: Methods and baseline resultsAlice R Pressman, Dawn C Buse, Alice S Jacobson, et al.
Diabetes|July 12, 2019
Myc Is Required for Adaptive β-Cell Replication in Young Mice but Is Not Sufficient in One-Year-Old Mice Fed With a High-Fat DietCarolina Rosselot, Anil Kumar, Jayalakshmi Lakshmipathi, et al.
Pageof 118

Showing results (941-950 of 1,171) with videos related to

Sort By:
Pageof 118
Allergy|January 14, 2018
Prevalence, severity, and risk factors for acute exacerbations of nasal and sinus symptoms by chronic rhinosinusitis statusJ R Kuiper, A G Hirsch, K Bandeen-Roche, et al.
Cancer|January 27, 2009
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group studyLisa M McGregor, Sheri L Spunt, Wayne L Furman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1988
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancyM Mangin, A C Webb, B E Dreyer, et al.
The Journal of Clinical Investigation|October 1, 1983
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cellsS B Rodan, K L Insogna, A M Vignery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Dose-response study of alendronate sodium for the treatment of cancer-associated hypercalcemiaS R Nussbaum, R P Warrell, R Rude, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumorsNajat C Daw, Victor M Santana, Lisa C Iacono, et al.
Cancer|January 2, 2009
Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumorsLisa M McGregor, Sheri L Spunt, Victor M Santana, et al.
Journal of Medical Microbiology|September 26, 2009
A quadruplex real-time PCR assay for rapid detection and differentiation of the Clostridium botulinum toxin genes A, B, E and FBenjamin A Satterfield, Alvin F Stewart, Cynthia S Lew, et al.
Headache|December 28, 2020
The migraine signature study: Methods and baseline resultsAlice R Pressman, Dawn C Buse, Alice S Jacobson, et al.
Diabetes|July 12, 2019
Myc Is Required for Adaptive β-Cell Replication in Young Mice but Is Not Sufficient in One-Year-Old Mice Fed With a High-Fat DietCarolina Rosselot, Anil Kumar, Jayalakshmi Lakshmipathi, et al.
Pageof 118